"Molecular Testing in Myeloproliferative Neoplasms: An overview and update"

At the conclusion of this activity, the participant will be able to:

1.   Clinical significance of DNA variants in chronic myeloproliferative neoplasm (CMN)
2.   Describe predictive and prognostic molecular biomarkers for chronic myeloproliferative neoplasm
3.   Understand various molecular testing methodologies, especially next generation sequencing, in CMN

 

plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Nasim Babaidorabad, MD, Hematopathology Fellow, Department of Pathology
Audience
All ( Open to the public )